Reporte zur Charge EN62NZ

Symptomtext

he got a rash on the arm where he had the second injection and he had a rash on his legs as well; This is a spontaneous report from contactable consumer (patient). An 84-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, administered in the right arm, on 26Feb2021 (Batch/lot number: EN62NZ), at age 84 years old, as dose 2, single, for COVID-19 immunisation. Relevant medical history included diabetes and chronic obstructive pulmonary disease (COPD) both from unknown dates, not reported if ongoing or not. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), administered in the right arm, on 05Feb2021 13:00 (Batch/lot number: EL342Z), at age 83 years old, as dose 1, single, for COVID-19 immunisation after which the patient experienced rash on legs. The patient did not receive other vaccine in four weeks. After the first dose, he had a rash on his legs. Then after the second dose, on 26Feb2021, he got a rash on the arm where he had the second injection and he had a rash on his legs as well. The patient did not receive treatment for the events. The outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.